ArticleOncotarget2017

A nomogram to predict HER2 status in breast cancer patients with HER2-borderline disease as determined via immunohistochemistry.

Qianqian Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.